FDG PET/CT–based Response Assessment in Malignancies

Keyphrases

• Malignancy 100%
• Fluorodeoxyglucose 100%
• Response Assessment 100%
• Positron Emission Tomography-computed Tomography (PET-CT) 75%
• Residual Disease 50%
• Residual Mass 50%
• Performance Prediction 25%
• Disease Process 25%
• Structural Information 25%
• Lymphoma 25%
• Glucose Metabolism 25%
• Clinical Setting 25%
• Glucose Uptake 25%
• Therapy Efficacy 25%
• Patient Management 25%
• Structural Change 25%
• Early Response 25%
• Functional Change 25%
• Objective Response 25%
• Solid Malignancies 25%
• Trial Design 25%
• Tumor Response Assessment 25%
• Fluorine-18 25%
• Tumor Necrosis 25%
• Assessment Criteria 25%
• Tumor Shrinkage 25%
• Functional Information 25%
• Response-adapted Therapy 25%
• Accurate Response 25%

Medicine and Dentistry

• Cancer 100%
• Deoxyglucose 100%
• Polyethylene Terephthalate 100%
• Positron Emission Tomography-Computed Tomography 75%
• Neoplasm 50%
• Minimal Residual Disease 50%
• Patient Care 25%
• Disease Process 25%
• Glucose Metabolism 25%
• Glucose Uptake 25%
• Fluorine-18 25%
• Necrosis 25%